Prostate Cancer
-
healthLarger Prostates Significantly Reduce Cancer Detection in Fusion Biopsy
A new study shows that increasing prostate volume leads to lower cancer detection rates using MRI-ultrasound fusion biopsy, highlighting diagnostic challenges.
-
healthAI Diagnostics Excel, But Human Doctors Remain Essential for Patient Care
AI models like ChatGPT now match or exceed doctors in diagnostic accuracy, but human physicians are irreplaceable for personalized treatment decisions and managing risk.
-
healthStockholm3 Blood Test Detects 90% of Aggressive Prostate Cancer, Outperforming PSA Screening
A new blood test, Stockholm3, identifies aggressive prostate cancer with 90% accuracy in trials, significantly improving upon the standard PSA test and potentially reducing unnecessary procedures.
-
healthStudy Links Low Testosterone to Higher Cancer Mortality Risk in Men
A major analysis of 26,000 men finds significantly lower testosterone levels are associated with increased risk of dying from cancer, except prostate cancer.
-
healthSingle-Fraction SBRT Promising for Prostate Cancer Treatment
Early trial results show single-fraction SBRT effectively controls localized prostate cancer with manageable side effects.
-
healthEnhancing Prostate Cancer Detection with Circulating Tumor Cells
New research highlights how circulating tumor cells can significantly improve prostate cancer diagnosis accuracy.
-
healthHigh-Risk Prostate Cancer Linked to Poorer Survival and Higher Costs Post-Surgery
A large U.S. study reveals high-risk localized prostate cancer patients face significantly lower survival rates and nearly $10,000 higher annual healthcare costs after radical prostatectomy compared to lower-risk groups.
-
healthDarolutamide Shows Cognitive Edge Over Enzalutamide in Prostate Cancer
New data from the ARACOG trial shows darolutamide causes less cognitive decline than enzalutamide in prostate cancer patients.